TCTR20210303005已完成1 期
Effects of cannabidiol rich cannabis extract on disease severity and quality of life in parkinson disease
/A0 个研究点目标入组 40 人开始时间: 2021年3月3日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 Years 至 90 Years（—）
- 性别
- All
入选标准
- •1.Clinical diagnosis of Parkinson disease, with a disease severity rating of stage 1 to 4 on the Hoehn and Yahr scale
- •2.stable medication use
排除标准
- •1.Dementia
- •2.History of ischemic heart disease or arrythmia
- •3.History of tobacco or alcoholic use
- •4.History of psychotic illness
- •5.History of opioid drug use
- •6.History of using drug that have drug interaction with cannabis extract
- •7.History of cannabis use
- •8.Pregnancy and lactation
- •9.Abnormal liver function test
- •10.Abnormal renal function test
研究者
相似试验
已完成
1 期
Effects of cannabidiol-enriched cannabis extraction product on cognitive functions and inflammatory markers in Parkinson disease.Parkinson diseaseCannabidiol enriched cannabis extraction product, Inflammatory marker, Parkinson disease, Cannabidiol, Cognitive functionTCTR20230204001Thai Traditional Medical Knowledge Fund60
招募中
3 期
Evaluation of the effect of cannabidiol in the treatment of dystoniaDystoniaIRCT20211019052811N1Mashhad University of Medical Sciences60
招募中
3 期
Effects of Inclusion of Cannabidiol in the Usual Treatment of Obsessive Compulsive DisorderObsessive-compulsive disorderRBR-467ksmbFaculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
已完成
不适用
Acute and chronic influences of cannabidiol on the ability to regenerate after strength and endurance trainingMuscle damage: CK and MyoInflammation: Il6 and Il 10DRKS00018770Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung 2 Molekulare und zelluläre Sportmedizin - Zentrum für präventive Doping Forschung26
招募中
2 期
Cannabidiol in Restless Leg SyndromeRestless Leg syndrome.Restless legs syndromeG25.81IRCT20210901052359N1Iran University of Medical Sciences40